• Astera Labs recently reported first-quarter 2026 results, with revenue of US$308.36 million and GAAP diluted EPS of US$0.44, issued second-quarter guidance for US$355 million to US$365 million in revenue and EPS of US$0.44 to US$0.46, and filed a US$2.05 billion shelf registration tied to an ESOP-related common share offering.
• The company also introduced its Scorpio X-Series 320-lane Smart Fabric Switch and expanded Scorpio P-Series family, paired with its COSMOS software, to target large-scale AI data center deployments with high-radix, memory-semantic connectivity designed to boost accelerator utilization and tokens-per-watt performance.
• We’ll now examine how Astera Labs’ stronger-than-expected earnings and upgraded second-quarter outlook may influence its AI-focused investment narrative.

Find 51 companies with promising cash flow potential yet trading below their fair value.

Astera Labs Investment Narrative Recap

To own Astera Labs, you need to believe AI data center buildouts will keep demanding high value interconnect and fabric solutions, and that Astera can stay at the heart of that spend despite customer concentration and fast moving standards. The Q1 2026 beat and stronger Q2 outlook reinforce the near term Scorpio ramp as the key catalyst, while rising competition and premium valuation remain the biggest risks; the new shelf filing does not materially change either, but it does add to dilution watchpoints.

Among recent announcements, the launch of the Scorpio X-Series 320 lane Smart Fabric Switch and expanded Scorpio P-Series stands out, because it directly aligns with the core catalyst of increasing Astera’s dollar content in scale up AI clusters. Shipping into a merchant switch silicon market projected at US$20 billion by 2030, this portfolio, tightly coupled with COSMOS software, is central to the thesis that Astera can deepen its role in hyperscale AI deployments.

Yet even with strong growth and product momentum, investors should be aware that Astera’s heavy reliance on hyperscaler AI capex leaves the story exposed if spending patterns or standards suddenly shift...

Astera Labs’ narrative projects $1.5 billion revenue and $393.5 million earnings by 2028.

Uncover how Astera Labs' forecasts yield a $204.47 fair value, a 5% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were already modeling revenue near US$3.2 billion and earnings above US$900 million by 2029, so if you buy into that much faster hyperscaler adoption and COSMOS monetization story, this latest beat and guidance could either reinforce their bullish case or prompt a rethink of just how far and how fast Astera’s AI exposure can really go.

Explore 15 other fair value estimates on Astera Labs - why the stock might be worth as much as 28% more than the current price!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Astera Labs research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Astera Labs research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Astera Labs' overall financial health at a glance.

Contemplating Other Strategies?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• This technology could replace computers: discover 27 stocks that are working to make quantum computing a reality.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 17 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.